Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report.

Tsai HL, Lu JW, Ho YJ, Lui SW, Hsieh TY, Wang KY, Liu FC

Open source

DOI
10.21873/invivo.14221
Published
2026 Jan-Feb
Container
In vivo (Athens, Greece)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21873/invivo.14221,
  title = {Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report.},
  author = {Tsai HL and Lu JW and Ho YJ and Lui SW and Hsieh TY and Wang KY and Liu FC},
  year = {2026},
  journal = {In vivo (Athens, Greece)},
  doi = {10.21873/invivo.14221},
  url = {https://doi.org/10.21873/invivo.14221}
}

RIS

TY  - JOUR
TI  - Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report.
AU  - Tsai HL
AU  - Lu JW
AU  - Ho YJ
AU  - Lui SW
AU  - Hsieh TY
AU  - Wang KY
AU  - Liu FC
PY  - 2026
JO  - In vivo (Athens, Greece)
DO  - 10.21873/invivo.14221
UR  - https://doi.org/10.21873/invivo.14221
ER  - 

APA

HL, T., JW, L., YJ, H., SW, L., TY, H., KY, W., & FC, L. (2026). Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case Report.. In vivo (Athens, Greece). https://doi.org/10.21873/invivo.14221

Source records